Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Duke University
ChineseAMS
Duke University
Fred Hutchinson Cancer Center
University of Rochester
M.D. Anderson Cancer Center
GlaxoSmithKline